Abdominal obesity is associated with an impaired fibrinolytic activity and elevated plasminogen activator inhibitor-1

This publication has 22 references indexed in Scilit:

• PLASMINOGEN ACTIVATOR INHIBITOR IN PLASMA: RISK FACTOR FOR RECURRENT MYOCARDIAL INFARCTION
  The Lancet, 1987
• HAEMOSTATIC FUNCTION AND ISCHAEMIC HEART DISEASE: PRINCIPAL RESULTS OF THE NORTHWICK PARK HEART STUDY
  The Lancet, 1986
• Increased Plasma Levels of a Rapid Inhibitor of Tissue Plasminogen Activator in Young Survivors of Myocardial Infarction
  New England Journal of Medicine, 1985
• The influence of body fat distribution on the incidence of diabetes mellitus. 13.5 years of follow-up of the participants in the study of men born in 1913
  Diabetes, 1985
• Distribution of adipose tissue and risk of cardiovascular disease and death: a 12 year follow up of participants in the population study of women in Gothenburg, Sweden.
  BMJ, 1984
• Fibrinogen as a Risk Factor for Stroke and Myocardial Infarction
  New England Journal of Medicine, 1984
• Abdominal adipose tissue distribution, obesity, and risk of cardiovascular disease and death: 13 year follow up of participants in the study of men born in 1913.
  BMJ, 1984
• Impact of obesity on metabolism in men and women. Importance of regional adipose tissue distribution.
  Journal of Clinical Investigation, 1983
• Relationship of Glucose Tolerance and Plasma Insulin to the Incidence of Coronary Heart Disease: Results from Two Population Studies in Finland
  Diabetes Care, 1979
• Coronary Heart Disease Incidence and Cardiovascular Mortality in Busselton with Reference to Glucose and Insulin Concentrations
  Diabetes Care, 1979